TOPIVERT

TopiVert is a clinical-stage biotechnology company developing next-generation, Narrow Spectrum Kinase Inhibitors (NSKIs) as novel, non-systemic medicines for the treatment of chronic inflammatory diseases of the gastrointestinal (GI) tract and the eye. The lead GI programme TOP1288 is currently in a Phase IIa proof of concept study in ulcerative colitis. A Phase I/II study with TOP1630 for dry eye syndrome will commence in the US in early 2017.

#People #Financial #Website #More

TOPIVERT

Social Links:

Twitter

Industry:

Angel Investment Biotechnology Health Care Management Information Systems

Founded:

2011-01-01

Address:

London, England, United Kingdom

Country:

United Kingdom

Website Url:

http://www.topivert.com

Total Employee:

Status:

Active

Email Addresses:

[email protected]

Total Funding:

19.9 M USD

Technology used in webpage:

Google Analytics Google Universal Analytics GoDaddy DNS ASP.NET IIS Pound Sterling IIS 8 Parallels Plesk Panel Plesk Classic ASP

Current Advisors List

maina-bhaman_image

Maina Bhaman Board of Directors @ TopiVert
Board_member

Current Employees Featured

not_available_image

Eric Charles Meldrum
Eric Charles Meldrum Founder @ TopiVert
Founder
2011-01-01

not_available_image

Steve Webber
Steve Webber Chief Scientific Officer @ TopiVert
Chief Scientific Officer
2011-11-01

Founder

not_available_image

Eric Charles Meldrum

Investors List

sv-life-sciences_image

Official Site Inspections

http://www.topivert.com Semrush global rank: 5.39 M Semrush visits lastest month: 1.56 K

Host Informations
Whois Informations

Loading ...